Text Size

Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities

This study has been completed.
Sponsor:
Information provided by:
University of Osnabrueck
ClinicalTrials.gov Identifier:
NCT01065610
First received: February 8, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
  Purpose

This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.


Condition Intervention
Coping Skills
Oxytocin
Stress
 Drug: Oxytocin
Drug: Placebo

Study Type: Interventional
Official Title: Oxytocin Buffers Cortisol Responses to Stress in Individuals With Impaired Coping Abilities

Resource links provided by NLM:

Drug Information available for: Oxytocin
U.S. FDA Resources

Further study details as provided by University of Osnabrueck:

Primary Outcome Measures:
  • Salivary Cortisol

Study Start Date: January 2008
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Oxytocin
Intranasal Oxytocin, 24 IU
 Drug: Oxytocin
Placebo Comparator: Placebo Drug: Placebo

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male

Exclusion Criteria:

  • psychological disorders
  • drug abuse
  • cigarette smoking
  • coronary diseases
  • nervous system diseases
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01065610     History of Changes
Other Study ID Numbers: Neurolab_RD_001
Study First Received: February 8, 2010
Last Updated: February 8, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Oxytocin
Oxytocics
Reproductive Control Agents
 Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on June 19, 2013